nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomilnacipran—CYP2C8—Colchicine—primary biliary cirrhosis	0.218	0.347	CbGbCtD
Levomilnacipran—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.175	0.278	CbGbCtD
Levomilnacipran—ABCB1—Colchicine—primary biliary cirrhosis	0.148	0.235	CbGbCtD
Levomilnacipran—CYP3A4—Colchicine—primary biliary cirrhosis	0.0886	0.141	CbGbCtD
Levomilnacipran—ABCB1—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00573	0.0812	CbGpPWpGaD
Levomilnacipran—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.00557	0.0186	CcSEcCtD
Levomilnacipran—CYP2J2—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.00493	0.0699	CbGpPWpGaD
Levomilnacipran—Bladder pain—Colchicine—primary biliary cirrhosis	0.00445	0.0149	CcSEcCtD
Levomilnacipran—ABCB1—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00434	0.0615	CbGpPWpGaD
Levomilnacipran—Cystitis noninfective—Ursodeoxycholic acid—primary biliary cirrhosis	0.00432	0.0144	CcSEcCtD
Levomilnacipran—Cystitis noninfective—Chenodeoxycholic acid—primary biliary cirrhosis	0.00432	0.0144	CcSEcCtD
Levomilnacipran—Cystitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00427	0.0143	CcSEcCtD
Levomilnacipran—Cystitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00427	0.0143	CcSEcCtD
Levomilnacipran—Bladder pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.004	0.0134	CcSEcCtD
Levomilnacipran—Bladder pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.004	0.0134	CcSEcCtD
Levomilnacipran—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51B—primary biliary cirrhosis	0.00353	0.05	CbGpPWpGaD
Levomilnacipran—Migraine—Ursodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0106	CcSEcCtD
Levomilnacipran—Migraine—Chenodeoxycholic acid—primary biliary cirrhosis	0.00316	0.0106	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Ursodeoxycholic acid—primary biliary cirrhosis	0.00297	0.0099	CcSEcCtD
Levomilnacipran—Liver function test abnormal—Chenodeoxycholic acid—primary biliary cirrhosis	0.00297	0.0099	CcSEcCtD
Levomilnacipran—ABCB1—Abacavir transmembrane transport—ABCG2—primary biliary cirrhosis	0.00296	0.042	CbGpPWpGaD
Levomilnacipran—Breast disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00969	CcSEcCtD
Levomilnacipran—Breast disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0029	0.00969	CcSEcCtD
Levomilnacipran—Neutropenia—Colchicine—primary biliary cirrhosis	0.00289	0.00965	CcSEcCtD
Levomilnacipran—Angina pectoris—Ursodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00903	CcSEcCtD
Levomilnacipran—Angina pectoris—Chenodeoxycholic acid—primary biliary cirrhosis	0.00271	0.00903	CcSEcCtD
Levomilnacipran—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—primary biliary cirrhosis	0.00267	0.0379	CbGpPWpGaD
Levomilnacipran—Haematuria—Colchicine—primary biliary cirrhosis	0.00263	0.00877	CcSEcCtD
Levomilnacipran—Dysuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00867	CcSEcCtD
Levomilnacipran—Dysuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.0026	0.00867	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00861	CcSEcCtD
Levomilnacipran—Upper respiratory tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00258	0.00861	CcSEcCtD
Levomilnacipran—Pollakiuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00856	CcSEcCtD
Levomilnacipran—Pollakiuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00257	0.00856	CcSEcCtD
Levomilnacipran—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00838	CcSEcCtD
Levomilnacipran—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00251	0.00838	CcSEcCtD
Levomilnacipran—Hypoaesthesia—Colchicine—primary biliary cirrhosis	0.00246	0.00822	CcSEcCtD
Levomilnacipran—Urinary tract infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00803	CcSEcCtD
Levomilnacipran—Urinary tract infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00241	0.00803	CcSEcCtD
Levomilnacipran—ABCB1—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00239	0.0339	CbGpPWpGaD
Levomilnacipran—Haematuria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00788	CcSEcCtD
Levomilnacipran—Haematuria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00236	0.00788	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00782	CcSEcCtD
Levomilnacipran—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00234	0.00782	CcSEcCtD
Levomilnacipran—Eye disorder—Colchicine—primary biliary cirrhosis	0.00231	0.00772	CcSEcCtD
Levomilnacipran—CYP2D6—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00225	0.032	CbGpPWpGaD
Levomilnacipran—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.00223	0.00744	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00733	CcSEcCtD
Levomilnacipran—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.0022	0.00733	CcSEcCtD
Levomilnacipran—Oedema peripheral—Ursodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00731	CcSEcCtD
Levomilnacipran—Oedema peripheral—Chenodeoxycholic acid—primary biliary cirrhosis	0.00219	0.00731	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00729	CcSEcCtD
Levomilnacipran—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00729	CcSEcCtD
Levomilnacipran—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00727	CcSEcCtD
Levomilnacipran—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00218	0.00727	CcSEcCtD
Levomilnacipran—Malnutrition—Colchicine—primary biliary cirrhosis	0.00215	0.00719	CcSEcCtD
Levomilnacipran—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00693	CcSEcCtD
Levomilnacipran—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00208	0.00693	CcSEcCtD
Levomilnacipran—Cardiac disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00688	CcSEcCtD
Levomilnacipran—Cardiac disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00206	0.00688	CcSEcCtD
Levomilnacipran—Angiopathy—Chenodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00673	CcSEcCtD
Levomilnacipran—Angiopathy—Ursodeoxycholic acid—primary biliary cirrhosis	0.00202	0.00673	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.002	0.00669	CcSEcCtD
Levomilnacipran—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.002	0.00669	CcSEcCtD
Levomilnacipran—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00666	CcSEcCtD
Levomilnacipran—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.00199	0.00666	CcSEcCtD
Levomilnacipran—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00646	CcSEcCtD
Levomilnacipran—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.00194	0.00646	CcSEcCtD
Levomilnacipran—Leukopenia—Colchicine—primary biliary cirrhosis	0.00193	0.00643	CcSEcCtD
Levomilnacipran—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00636	CcSEcCtD
Levomilnacipran—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.00191	0.00636	CcSEcCtD
Levomilnacipran—Tension—Ursodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00634	CcSEcCtD
Levomilnacipran—Tension—Chenodeoxycholic acid—primary biliary cirrhosis	0.0019	0.00634	CcSEcCtD
Levomilnacipran—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00579	CcSEcCtD
Levomilnacipran—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.00174	0.00579	CcSEcCtD
Levomilnacipran—Leukopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00578	CcSEcCtD
Levomilnacipran—Leukopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00173	0.00578	CcSEcCtD
Levomilnacipran—Shock—Colchicine—primary biliary cirrhosis	0.00173	0.00577	CcSEcCtD
Levomilnacipran—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.00172	0.00575	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.00172	0.00574	CcSEcCtD
Levomilnacipran—Palpitations—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00571	CcSEcCtD
Levomilnacipran—Palpitations—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00571	CcSEcCtD
Levomilnacipran—Skin disorder—Colchicine—primary biliary cirrhosis	0.00171	0.0057	CcSEcCtD
Levomilnacipran—ABCB1—Abacavir transport and metabolism—ABCG2—primary biliary cirrhosis	0.0017	0.0241	CbGpPWpGaD
Levomilnacipran—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00568	CcSEcCtD
Levomilnacipran—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.0017	0.00568	CcSEcCtD
Levomilnacipran—Convulsion—Chenodeoxycholic acid—primary biliary cirrhosis	0.00168	0.0056	CcSEcCtD
Levomilnacipran—Convulsion—Ursodeoxycholic acid—primary biliary cirrhosis	0.00168	0.0056	CcSEcCtD
Levomilnacipran—Hypertension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00167	0.00558	CcSEcCtD
Levomilnacipran—Hypertension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00167	0.00558	CcSEcCtD
Levomilnacipran—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00165	0.0055	CcSEcCtD
Levomilnacipran—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00165	0.0055	CcSEcCtD
Levomilnacipran—Hypotension—Colchicine—primary biliary cirrhosis	0.00164	0.00548	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00546	CcSEcCtD
Levomilnacipran—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00164	0.00546	CcSEcCtD
Levomilnacipran—Dry mouth—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00538	CcSEcCtD
Levomilnacipran—Dry mouth—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00538	CcSEcCtD
Levomilnacipran—CYP2J2—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.00158	0.0225	CbGpPWpGaD
Levomilnacipran—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00524	CcSEcCtD
Levomilnacipran—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.00157	0.00524	CcSEcCtD
Levomilnacipran—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00519	CcSEcCtD
Levomilnacipran—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00519	CcSEcCtD
Levomilnacipran—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00517	CcSEcCtD
Levomilnacipran—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00517	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00516	CcSEcCtD
Levomilnacipran—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00516	CcSEcCtD
Levomilnacipran—Tachycardia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00514	CcSEcCtD
Levomilnacipran—Tachycardia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00154	0.00514	CcSEcCtD
Levomilnacipran—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00512	CcSEcCtD
Levomilnacipran—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.00512	CcSEcCtD
Levomilnacipran—Decreased appetite—Colchicine—primary biliary cirrhosis	0.00153	0.0051	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00153	0.0051	CcSEcCtD
Levomilnacipran—Hyperhidrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00153	0.0051	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.00152	0.00506	CcSEcCtD
Levomilnacipran—Fatigue—Colchicine—primary biliary cirrhosis	0.00152	0.00506	CcSEcCtD
Levomilnacipran—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00502	CcSEcCtD
Levomilnacipran—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00151	0.00502	CcSEcCtD
Levomilnacipran—Hypotension—Ursodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00492	CcSEcCtD
Levomilnacipran—Hypotension—Chenodeoxycholic acid—primary biliary cirrhosis	0.00148	0.00492	CcSEcCtD
Levomilnacipran—CYP3A4—Codeine and Morphine Metabolism—ABCC2—primary biliary cirrhosis	0.00147	0.0209	CbGpPWpGaD
Levomilnacipran—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.00144	0.0048	CcSEcCtD
Levomilnacipran—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00477	CcSEcCtD
Levomilnacipran—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00143	0.00477	CcSEcCtD
Levomilnacipran—Paraesthesia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00473	CcSEcCtD
Levomilnacipran—Paraesthesia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00142	0.00473	CcSEcCtD
Levomilnacipran—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0047	CcSEcCtD
Levomilnacipran—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00141	0.0047	CcSEcCtD
Levomilnacipran—Somnolence—Chenodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00469	CcSEcCtD
Levomilnacipran—Somnolence—Ursodeoxycholic acid—primary biliary cirrhosis	0.0014	0.00469	CcSEcCtD
Levomilnacipran—Urticaria—Colchicine—primary biliary cirrhosis	0.0014	0.00466	CcSEcCtD
Levomilnacipran—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00464	CcSEcCtD
Levomilnacipran—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00139	0.00464	CcSEcCtD
Levomilnacipran—Abdominal pain—Colchicine—primary biliary cirrhosis	0.00139	0.00464	CcSEcCtD
Levomilnacipran—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00458	CcSEcCtD
Levomilnacipran—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.00137	0.00458	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00455	CcSEcCtD
Levomilnacipran—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00455	CcSEcCtD
Levomilnacipran—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00454	CcSEcCtD
Levomilnacipran—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.00136	0.00454	CcSEcCtD
Levomilnacipran—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00451	CcSEcCtD
Levomilnacipran—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00135	0.00451	CcSEcCtD
Levomilnacipran—ABCB1—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.00131	0.0186	CbGpPWpGaD
Levomilnacipran—Hypersensitivity—Colchicine—primary biliary cirrhosis	0.00129	0.00432	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00431	CcSEcCtD
Levomilnacipran—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00129	0.00431	CcSEcCtD
Levomilnacipran—Asthenia—Colchicine—primary biliary cirrhosis	0.00126	0.00421	CcSEcCtD
Levomilnacipran—Urticaria—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00419	CcSEcCtD
Levomilnacipran—Urticaria—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00419	CcSEcCtD
Levomilnacipran—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00417	CcSEcCtD
Levomilnacipran—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00417	CcSEcCtD
Levomilnacipran—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00417	CcSEcCtD
Levomilnacipran—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00125	0.00417	CcSEcCtD
Levomilnacipran—Diarrhoea—Colchicine—primary biliary cirrhosis	0.0012	0.00401	CcSEcCtD
Levomilnacipran—Hypersensitivity—Chenodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00388	CcSEcCtD
Levomilnacipran—Hypersensitivity—Ursodeoxycholic acid—primary biliary cirrhosis	0.00116	0.00388	CcSEcCtD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.00114	0.0162	CbGpPWpGaD
Levomilnacipran—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00378	CcSEcCtD
Levomilnacipran—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00113	0.00378	CcSEcCtD
Levomilnacipran—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—primary biliary cirrhosis	0.00112	0.0159	CbGpPWpGaD
Levomilnacipran—Vomiting—Colchicine—primary biliary cirrhosis	0.00112	0.00373	CcSEcCtD
Levomilnacipran—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00373	CcSEcCtD
Levomilnacipran—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.00112	0.00373	CcSEcCtD
Levomilnacipran—Rash—Colchicine—primary biliary cirrhosis	0.00111	0.0037	CcSEcCtD
Levomilnacipran—Dermatitis—Colchicine—primary biliary cirrhosis	0.00111	0.0037	CcSEcCtD
Levomilnacipran—Headache—Colchicine—primary biliary cirrhosis	0.0011	0.00367	CcSEcCtD
Levomilnacipran—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00361	CcSEcCtD
Levomilnacipran—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.00108	0.00361	CcSEcCtD
Levomilnacipran—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00349	CcSEcCtD
Levomilnacipran—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.00104	0.00349	CcSEcCtD
Levomilnacipran—Nausea—Colchicine—primary biliary cirrhosis	0.00104	0.00348	CcSEcCtD
Levomilnacipran—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.001	0.00335	CcSEcCtD
Levomilnacipran—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.001	0.00335	CcSEcCtD
Levomilnacipran—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000996	0.00332	CcSEcCtD
Levomilnacipran—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000996	0.00332	CcSEcCtD
Levomilnacipran—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000995	0.00332	CcSEcCtD
Levomilnacipran—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000995	0.00332	CcSEcCtD
Levomilnacipran—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000989	0.0033	CcSEcCtD
Levomilnacipran—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000989	0.0033	CcSEcCtD
Levomilnacipran—CYP3A4—Irinotecan Pathway—ABCC2—primary biliary cirrhosis	0.000942	0.0134	CbGpPWpGaD
Levomilnacipran—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000938	0.00313	CcSEcCtD
Levomilnacipran—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000938	0.00313	CcSEcCtD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000912	0.0129	CbGpPWpGaD
Levomilnacipran—SLC6A4—Monoamine Transport—AGT—primary biliary cirrhosis	0.000902	0.0128	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—SLC4A2—primary biliary cirrhosis	0.000842	0.0119	CbGpPWpGaD
Levomilnacipran—CYP2C19—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000809	0.0115	CbGpPWpGaD
Levomilnacipran—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—primary biliary cirrhosis	0.000807	0.0114	CbGpPWpGaD
Levomilnacipran—CYP3A4—Irinotecan Pathway—ABCG2—primary biliary cirrhosis	0.000801	0.0114	CbGpPWpGaD
Levomilnacipran—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000789	0.0112	CbGpPWpGaD
Levomilnacipran—SLC6A2—Monoamine Transport—AGT—primary biliary cirrhosis	0.000775	0.011	CbGpPWpGaD
Levomilnacipran—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000752	0.0107	CbGpPWpGaD
Levomilnacipran—ABCB1—ABC-family proteins mediated transport—ABCC2—primary biliary cirrhosis	0.000718	0.0102	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—primary biliary cirrhosis	0.000705	0.01	CbGpPWpGaD
Levomilnacipran—CYP3A4—Tryptophan metabolism—OGDH—primary biliary cirrhosis	0.000661	0.00937	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000619	0.00878	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—AQP4—primary biliary cirrhosis	0.000612	0.00868	CbGpPWpGaD
Levomilnacipran—CYP2J2—Biological oxidations—GGT1—primary biliary cirrhosis	0.00059	0.00836	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000552	0.00783	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—ABCC2—primary biliary cirrhosis	0.000532	0.00755	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCR5—primary biliary cirrhosis	0.000487	0.0069	CbGpPWpGaD
Levomilnacipran—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—primary biliary cirrhosis	0.000486	0.0069	CbGpPWpGaD
Levomilnacipran—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—primary biliary cirrhosis	0.000477	0.00677	CbGpPWpGaD
Levomilnacipran—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—primary biliary cirrhosis	0.000463	0.00657	CbGpPWpGaD
Levomilnacipran—CYP3A4—Aflatoxin activation and detoxification—GGT1—primary biliary cirrhosis	0.000461	0.00653	CbGpPWpGaD
Levomilnacipran—CYP2C19—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000449	0.00637	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CXCL9—primary biliary cirrhosis	0.000442	0.00626	CbGpPWpGaD
Levomilnacipran—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.000438	0.00622	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL12A—primary biliary cirrhosis	0.00043	0.00609	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000428	0.00607	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—IGFBP1—primary biliary cirrhosis	0.000422	0.00598	CbGpPWpGaD
Levomilnacipran—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—primary biliary cirrhosis	0.00041	0.00581	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—LBR—primary biliary cirrhosis	0.000406	0.00576	CbGpPWpGaD
Levomilnacipran—CYP2C8—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000396	0.00561	CbGpPWpGaD
Levomilnacipran—SLC6A4—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000386	0.00548	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—ABCG2—primary biliary cirrhosis	0.000376	0.00533	CbGpPWpGaD
Levomilnacipran—CYP2C19—Arachidonic acid metabolism—GGT1—primary biliary cirrhosis	0.000353	0.00501	CbGpPWpGaD
Levomilnacipran—SLC6A2—NRF2 pathway—GGT1—primary biliary cirrhosis	0.000332	0.00471	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—PPARGC1A—primary biliary cirrhosis	0.000326	0.00462	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—NUP210—primary biliary cirrhosis	0.000307	0.00435	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—OGDH—primary biliary cirrhosis	0.000294	0.00416	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—DAG1—primary biliary cirrhosis	0.000273	0.00387	CbGpPWpGaD
Levomilnacipran—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—primary biliary cirrhosis	0.00027	0.00383	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL12B—primary biliary cirrhosis	0.00027	0.00383	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—PPARGC1A—primary biliary cirrhosis	0.000266	0.00377	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	0.000265	0.00375	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PDHX—primary biliary cirrhosis	0.000262	0.00371	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—HIF1A—primary biliary cirrhosis	0.000255	0.00361	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CTLA4—primary biliary cirrhosis	0.000254	0.0036	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—DLAT—primary biliary cirrhosis	0.000246	0.00349	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ABCB4—primary biliary cirrhosis	0.000246	0.00349	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000228	0.00323	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	0.000226	0.00321	CbGpPWpGaD
Levomilnacipran—CYP2C19—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000221	0.00313	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—LBR—primary biliary cirrhosis	0.000203	0.00288	CbGpPWpGaD
Levomilnacipran—CYP2D6—Melatonin metabolism and effects—NFKB1—primary biliary cirrhosis	0.000203	0.00288	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	0.000202	0.00286	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CD40LG—primary biliary cirrhosis	0.000197	0.0028	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—HIF1A—primary biliary cirrhosis	0.000192	0.00272	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—IL4—primary biliary cirrhosis	0.000192	0.00272	CbGpPWpGaD
Levomilnacipran—SLC6A4—Circadian rythm related genes—NOS2—primary biliary cirrhosis	0.000189	0.00268	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—SLC4A2—primary biliary cirrhosis	0.000189	0.00267	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	0.000178	0.00252	CbGpPWpGaD
Levomilnacipran—ABCB1—HIF-1-alpha transcription factor network—NOS2—primary biliary cirrhosis	0.000175	0.00248	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	0.00017	0.00242	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	0.000157	0.00223	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	0.000156	0.00221	CbGpPWpGaD
Levomilnacipran—SLC6A4—SIDS Susceptibility Pathways—NFKB1—primary biliary cirrhosis	0.000148	0.0021	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—NUP210—primary biliary cirrhosis	0.000148	0.0021	CbGpPWpGaD
Levomilnacipran—CYP2C8—Biological oxidations—GGT1—primary biliary cirrhosis	0.000147	0.00209	CbGpPWpGaD
Levomilnacipran—ABCB1—Allograft Rejection—CD80—primary biliary cirrhosis	0.000147	0.00208	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	0.000145	0.00206	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000138	0.00196	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ABCG2—primary biliary cirrhosis	0.000137	0.00195	CbGpPWpGaD
Levomilnacipran—CYP2C19—Biological oxidations—GGT1—primary biliary cirrhosis	0.000131	0.00186	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—primary biliary cirrhosis	0.000127	0.0018	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—primary biliary cirrhosis	0.000123	0.00175	CbGpPWpGaD
Levomilnacipran—CYP2D6—Biological oxidations—GGT1—primary biliary cirrhosis	0.000121	0.00171	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	0.00012	0.00171	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—CTGF—primary biliary cirrhosis	0.000118	0.00167	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT2—primary biliary cirrhosis	0.000117	0.00166	CbGpPWpGaD
Levomilnacipran—SLC6A2—SLC-mediated transmembrane transport—ALB—primary biliary cirrhosis	0.000111	0.00158	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—LBR—primary biliary cirrhosis	0.000101	0.00144	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GOT1—primary biliary cirrhosis	0.000101	0.00143	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—GGT1—primary biliary cirrhosis	0.000101	0.00143	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—LBR—primary biliary cirrhosis	9.05e-05	0.00128	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—PPARGC1A—primary biliary cirrhosis	8.98e-05	0.00127	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—LBR—primary biliary cirrhosis	8.83e-05	0.00125	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—LBR—primary biliary cirrhosis	8.32e-05	0.00118	CbGpPWpGaD
Levomilnacipran—CYP3A4—Biological oxidations—GGT1—primary biliary cirrhosis	7.9e-05	0.00112	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	7.83e-05	0.00111	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	7.51e-05	0.00106	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—OGDH—primary biliary cirrhosis	7.33e-05	0.00104	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—AGT—primary biliary cirrhosis	6.99e-05	0.000991	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	6.86e-05	0.000973	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	6.61e-05	0.000937	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—OGDH—primary biliary cirrhosis	6.54e-05	0.000927	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	6.53e-05	0.000926	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	6.38e-05	0.000905	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	6.38e-05	0.000905	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	6.14e-05	0.000871	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	6.14e-05	0.000871	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	6.02e-05	0.000853	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	5.9e-05	0.000837	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PDHX—primary biliary cirrhosis	5.83e-05	0.000827	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	5.69e-05	0.000807	CbGpPWpGaD
Levomilnacipran—SLC6A2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	5.66e-05	0.000802	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.65e-05	0.000802	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—DLAT—primary biliary cirrhosis	5.48e-05	0.000777	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCB4—primary biliary cirrhosis	5.48e-05	0.000777	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	5.44e-05	0.000771	CbGpPWpGaD
Levomilnacipran—CYP2J2—Metabolism—ALB—primary biliary cirrhosis	5.37e-05	0.000761	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	5.36e-05	0.00076	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	5.35e-05	0.000759	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	5.35e-05	0.000759	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	5.05e-05	0.000716	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	5.04e-05	0.000715	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	5.04e-05	0.000715	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	5.03e-05	0.000714	CbGpPWpGaD
Levomilnacipran—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	4.76e-05	0.000676	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	4.49e-05	0.000637	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	3.93e-05	0.000558	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.92e-05	0.000556	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	3.69e-05	0.000523	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	3.51e-05	0.000497	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	3.5e-05	0.000496	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	3.43e-05	0.000486	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	3.3e-05	0.000467	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	3.3e-05	0.000467	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—NUP210—primary biliary cirrhosis	3.29e-05	0.000467	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	3.22e-05	0.000456	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ABCG2—primary biliary cirrhosis	3.06e-05	0.000434	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	3.03e-05	0.00043	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	3.01e-05	0.000426	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	2.99e-05	0.000424	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	2.94e-05	0.000417	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	2.92e-05	0.000414	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	2.82e-05	0.000399	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	2.68e-05	0.000381	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—CTGF—primary biliary cirrhosis	2.63e-05	0.000373	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT2—primary biliary cirrhosis	2.6e-05	0.000369	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	2.56e-05	0.000364	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	2.54e-05	0.00036	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	2.52e-05	0.000357	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	2.52e-05	0.000357	CbGpPWpGaD
Levomilnacipran—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	2.49e-05	0.000353	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	2.42e-05	0.000343	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	2.39e-05	0.00034	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GGT1—primary biliary cirrhosis	2.25e-05	0.000319	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—GOT1—primary biliary cirrhosis	2.25e-05	0.000319	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	2.24e-05	0.000318	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	2.19e-05	0.000311	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	2.19e-05	0.000311	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	2.07e-05	0.000293	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	2.07e-05	0.000293	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—PPARGC1A—primary biliary cirrhosis	2e-05	0.000284	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	1.98e-05	0.000281	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.95e-05	0.000277	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	1.84e-05	0.000261	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	1.84e-05	0.000261	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	1.75e-05	0.000248	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	1.58e-05	0.000224	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	1.57e-05	0.000222	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—AGT—primary biliary cirrhosis	1.56e-05	0.000221	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—AGT—primary biliary cirrhosis	1.52e-05	0.000216	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	1.43e-05	0.000203	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	1.35e-05	0.000192	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	1.35e-05	0.000192	CbGpPWpGaD
Levomilnacipran—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	1.34e-05	0.00019	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	1.2e-05	0.000171	CbGpPWpGaD
Levomilnacipran—CYP2C19—Metabolism—ALB—primary biliary cirrhosis	1.2e-05	0.00017	CbGpPWpGaD
Levomilnacipran—ABCB1—Metabolism—ALB—primary biliary cirrhosis	1.17e-05	0.000165	CbGpPWpGaD
Levomilnacipran—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	1.1e-05	0.000156	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	9.37e-06	0.000133	CbGpPWpGaD
Levomilnacipran—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	7.19e-06	0.000102	CbGpPWpGaD
